Let's get small (and smaller): Combining zebrafish and nanomedicine to advance neuroregenerative therapeutics

David T. White, Meera T. Saxena, Jeff S. Mumm

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations


Several key attributes of zebrafish make them an ideal model system for the discovery and development of regeneration promoting therapeutics; most notably their robust capacity for self-repair which extends to the central nervous system. Further, by enabling large-scale drug discovery directly in living vertebrate disease models, zebrafish circumvent critical bottlenecks which have driven drug development costs up. This review summarizes currently available zebrafish phenotypic screening platforms, HTS-ready neurodegenerative disease modeling strategies, zebrafish small molecule screens which have succeeded in identifying regeneration promoting compounds and explores how intravital imaging in zebrafish can facilitate comprehensive analysis of nanocarrier biodistribution and pharmacokinetics. Finally, we discuss the benefits and challenges attending the combination of zebrafish and nanoparticle-based drug optimization, highlighting inspiring proof-of-concept studies and looking toward implementation across the drug development community.

Original languageEnglish (US)
Pages (from-to)344-359
Number of pages16
JournalAdvanced Drug Delivery Reviews
StatePublished - Aug 2019


  • Drug optimization
  • Nanocarrier
  • Neurodegeneration
  • Neuroregeneration

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Let's get small (and smaller): Combining zebrafish and nanomedicine to advance neuroregenerative therapeutics'. Together they form a unique fingerprint.

Cite this